Cited by 168

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Age-Related Impairment of Synaptic Transmission But Normal Long-Term Potentiation in Transgenic Mice that Overexpress the Human APP695SWE Mutant Form of Amyloid Precursor Protein

Fitzjohn, Stephen M., Morton, Robin A., Kuenzi, Frederick, Rosahl, Thomas W., Shearman, Mark, Lewis, Huw, Smith, David, Reynolds, David S., Davies, Ceri H., Collingridge, Graham L., Seabrook, Guy R.·2001·The Journal of Neuroscience

Abstract

We have studied synaptic function in a transgenic mouse strain relevant to Alzheimer's disease (AD), overexpressing the 695 amino acid isoform of human amyloid precursor protein with K670N and M671L mutations (APP 695 SWE mice), which is associated with early-onset familial AD. Aged-transgenic mice had substantially elevated levels of Aβ (up to 22 μmol/gm) and displayed characteristic Aβ plaques. Hippocampal slices from 12-month-old APP 695 SWE transgenic animals displayed reduced levels of synaptic transmission in the CA1 region when compared with wild-type littermate controls. Inclusion of the ionotropic glutamate receptor antagonist kynurenate during preparation of brain slices abolished this deficit. At 18 months of age, a selective deficit in basal synaptic transmission was observed in the CA1 region despite treatment with kynurenate. Paired-pulse facilitation and long-term potentiation (LTP) were normal in APP 695 SWE transgenic mice at both 12 and 18 months of age. Thus, although aged APP 695 SWE transgenic mice have greatly elevated levels of Aβ protein, increased numbers of plaques, and reduced basal synaptic transmission, LTP can still be induced and expressed normally. We conclude that increased susceptibility to excitotoxicity rather than a specific effect on LTP is the primary cause of cognitive deficits in APP 695 SWE mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.21-13-04691.2001

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Posttetanic potentiation and long-term potentiation in the CA1 area were apparently normal in Tg2576 hippocampal slices at both ages.

    “Note that posttetanic potentiation and LTP in the CA1 area were apparently normal in Tg2576 hippocampal slices at both ages, which is in agreement with previous reports that LTP was not impaired until at the age of >12 mo old (Chapman et al., 1999; Fitzjohn et al., 2001).”

    From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Fitzjohn et al., 2001

    The CA1 synaptic-plasticity results (page unavailable) report normal LTP in transgenic slices at both 12 and 18 months. The paper does not report posttetanic potentiation; it measures paired-pulse facilitation instead. Its finding of normal LTP at 18 months also does not support the sentence’s implication that LTP becomes impaired after 12 months. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • In the Schaffer collateral pathway (SC-CA1), the deficiency was not detectable until 12-18 months old.

    “In the Schaffer collateral (SC) pathway (SC-CA1), the deficiency was not detectable until 12–18 mo old (Chapman et al., 1999; Fitzjohn et al., 2001).”

    From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Fitzjohn et al., 2001

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Anderson, 1997, A data acquisition program for on-line analysis of long-term potentiation and long-term depression., Soc Neurosci Abstr, 23, 665
  2. 10.1016/S0896-6273(00)80230-5 · DOI · Paper page
  3. Chapman, 1997, Abnormal synaptic transmission in aged APP transgenic mice., J Physiol (Lond), 501, 95.P
  4. 10.1038/6374 · DOI · Paper page
  5. 10.1523/JNEUROSCI.10-08-02493.1990 · DOI
  6. 10.1042/bst0180390 · DOI
  7. 10.1016/S0306-4522(98)00410-2 · DOI
  8. 10.1016/S0304-3940(00)01204-0 · DOI
  9. Frautschy, 1998, Microglial response to amyloid plaques in APPSW transgenic mice., Am J Pathol, 152, 307
  10. 10.1002/(SICI)1098-1063(1999)9:3<201::AID-HIPO1>3.0.CO;2-P · DOI
  11. 10.1016/S0006-8993(00)02615-9 · DOI
  12. 10.1016/S0166-2236(96)01030-2 · DOI · Paper page
  13. Hsiao, 1995, Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins., Neuron, 25, 1203, 10.1016/0896-6273(95)90107-8 · DOI
  14. 10.1126/science.274.5284.99 · DOI · Paper page
  15. 10.1096/fj.14.11.1508 · DOI
  16. 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W · DOI
  17. Kuenzi, 1999, The rd mutation in cGMP PDE-IV does not affect synaptic plasticity in mouse hippocampus., Soc Neurosci Abstr, 25, 398.9
  18. 10.1016/S0006-8993(99)01698-4 · DOI
  19. 10.1097/00005072-199708000-00008 · DOI · Paper page
  20. 10.1016/0166-2236(94)90008-6 · DOI
  21. 10.1016/0896-6273(93)90315-I · DOI · Paper page
  22. 10.1523/JNEUROSCI.20-04-01358.2000 · DOI
  23. 10.1212/WNL.34.7.939 · DOI · Paper page
  24. 10.1074/jbc.274.10.6483 · DOI · Paper page
  25. Morton, 1999, Selective disruption of late-phase LTP in mice under-expressing presenilin-1., Soc Neurosci Abstr, 25, 398.10
  26. 10.1038/387500a0 · DOI
  27. 10.1016/S0166-2236(97)01168-5 · DOI
  28. 10.1006/nbdi.1998.0207 · DOI
  29. 10.1146/annurev.neuro.21.1.479 · DOI
  30. Seabrook, 1999, Transgenic animals relevant to Alzheimer's disease., Neuropharmacology, 38, 1, 10.1016/S0028-3908(98)00170-1 · DOI
  31. 10.1016/S0028-3908(98)00204-4 · DOI
  32. 10.1016/S0896-6273(00)00125-2 · DOI
  33. Wimer, 1991, The mouse gene retinal degeneration (rd) may reduce the number of neurons present in the adult hippocampal dentate gyrus., Brain Res, 547, 275, 10.1016/0006-8993(91)90971-W · DOI
  34. 10.1016/S0306-4522(97)00053-5 · DOI
  35. 10.1006/nbdi.1999.0271 · DOI

Cited by

Sorted by citations

Metadata

Authors
Fitzjohn, S. M., Morton, R. A., Kuenzi, F., Rosahl, T. W., Shearman, M., Lewis, H., Smith, D., Reynolds, D. S., Davies, C. H., Collingridge, G. L., & Seabrook, G. R.
Venue
The Journal of Neuroscience
Published
2001-07-01
Volume
21
Issue
13
Pages
4691-4698
ISSN
  • 0270-6474
  • 1529-2401
Cited by
168
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review